Skip to main content
Log in

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

A standard practice in health economic evaluation is to monetize health effects by assuming a certain societal willingness-to-pay per unit of health gain. Although the resulting net monetary benefit (NMB) is easy to compute, the use of a single willingness-to-pay threshold assumes expressibility of the health effects on a single non-monetary scale. To relax this assumption, this article proves that the NMB framework is a special case of the more general stochastic multi-criteria acceptability analysis (SMAA) method. Specifically, as SMAA does not restrict the number of criteria to two and also does not require the marginal rates of substitution to be constant, there are problem instances for which the use of this more general method may result in a better understanding of the trade-offs underlying the reimbursement decision-making problem. This is illustrated by applying both methods in a case study related to infertility treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Al, M., Feenstra, T., Van Hout, B.: Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty. Health Econ. 14(7), 655–667 (2005). doi:10.1002/hec.973

    Article  PubMed  Google Scholar 

  2. Belton, V., Stewart, T.J.: Multiple criteria decision analysis—an integrated approach. Kluwer Academic Publishers, Dordrecht (2002)

    Book  Google Scholar 

  3. Briggs, A.H., Claxton, K., Sculpher, M.: Decision modelling for health economic evaluation. Oxford University Press, Oxford (2006)

    Google Scholar 

  4. Brouwer, W., Koopmanschap, M.: On the economic foundations of CEA. ladies and gentlemen, take your positions! J. Health Econ. 19(4), 439–459 (2000). doi:10.1016/S0167-6296(99)00038-7

    Article  CAS  PubMed  Google Scholar 

  5. Choo, E.U., Schoner, B., Wedley, W.C.: Interpretation of criteria weights in multicriteria decision making. Comput. Ind. Eng. 37(3), 527–541 (1999). doi:10.1016/S0360-8352(00)00019-X

    Article  Google Scholar 

  6. Claxton, K., Posnett, J.: An economic approach to clinical trial design and research priority-setting. Health Econ. 5(6), 513–524 (1998). doi:10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9

    Article  Google Scholar 

  7. Dolan, P., Edlin, R.: Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? J. Health Econ. 21(5), 827–43 (2002). doi:10.1016/S0167-6296(02)00011-5

    Article  PubMed  Google Scholar 

  8. Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (2005)

    Google Scholar 

  9. Eichler, H., Kong, S., Gerth, W., Mavros, P., Jönsson, B.: Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value in Health 7(5), 518–528 (2004). doi:10.1111/j.1524-4733.2004.75003.x

    Article  PubMed  Google Scholar 

  10. Elixhauser, A., Halpern, M., Schmier, J., Luce, B.: Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med. Care 36(5), MS1–MS9 (1998). doi:10.1097/00005650-199805001-00001

    CAS  PubMed  Google Scholar 

  11. Fenwick, E., Claxton, K., Sculpher, M.: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 10(8), 779–787 (2001). doi:10.1002/hec.635

    Article  CAS  PubMed  Google Scholar 

  12. Fiddelers, A.A.A., Dirksen, C.D., Dumoulin, J., van Montfoort, A., Land, J.A., Janssen, J.M., Evers, J.L.H., Severens, J.L.: Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Hum. Reprod. 24(7), 1648–1655 (2009). doi:10.1093/humrep/dep041

    Article  PubMed  Google Scholar 

  13. Goetghebeur, M., Wagner, M., Khoury, H., Levitt, R., Erickson, L., Rindress, D.: Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the evidem framework to medicines appraisal. Med. Decis. Making 32(2), 376–388 (2012). doi:10.1177/0272989X11416870

    Article  PubMed  Google Scholar 

  14. Keeney, R., Raiffa, H.: Decisions with multiple objectives: preferences and value tradeoffs. Wiley, New York (1976)

    Google Scholar 

  15. Lahdelma, R., Salminen, P.: SMAA-2: Stochastic multicriteria acceptability analysis for group decision making. Oper. Res. 49(3), 444–454 (2001). doi:10.1287/opre.49.3.444.11220

    Article  Google Scholar 

  16. Stinnett, A., Paltiel, A. et al.: Mathematical programming for the efficient allocation of health care resources. J. Health Econ. 15(5), 641–654 (1996). doi:10.1016/S0167-6296(96)00493-6

    Article  CAS  PubMed  Google Scholar 

  17. Tervonen, T., van Valkenhoef, G., Buskens, E., Hillege, H.L., Postmus, D.: A stochastic multi-criteria model for evidence-based decision making in drug benefit-risk analysis. Stat. Med. 30(12), 1419–1428 (2011). doi:10.1002/sim.4194

    Article  PubMed  Google Scholar 

  18. Thokala, P., Duenas, A.: Multiple criteria decision analysis for health technology assessment. Value Health 15(8), 1172–1181 (2012). doi:10.1016/j.jval.2012.06.015

    Article  PubMed  Google Scholar 

  19. van Valkenhoef, G., Tervonen, T., Zhao, J., de Brock, B., Hillege, H.L., Postmus, D.: Multi-criteria benefit-risk assessment using network meta-analysis. J. Clin. Epidemiol. 65(4), 394–403 (2012). doi:10.1016/j.jclinepi.2011.09.005

    Article  PubMed  Google Scholar 

  20. Van Hout, B., Al, M., Gordon, G., Rutten, F.: Costs, effects and c/e-ratios alongside a clinical trial. Health Econ. 3(5), 309–319 (1994). doi:10.1002/hec.4730030505

    Article  CAS  PubMed  Google Scholar 

  21. Weinstein, M., Zeckhauser, R.: Critical ratios and efficient allocation. J. Public Econ. 2(2), 147–157 (1973). doi:10.1016/0047-2727(73)90002-9

    Article  Google Scholar 

Download references

Acknowledgments

This research was conducted within the framework of the Center for Translational Molecular Medicine, project PREDICCt (grant 01C-104) and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation, and Dutch Kidney Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Douwe Postmus.

Appendix

Appendix

Define V 1(e) = λ e and V 2(c) =  − c, and consider the NMB function

$$ \hbox{NMB}(c^{i},e^{i},\lambda) = \lambda e^{i} - c^{i} = V_{1}(e^{i}) + V_{2}(c^{i}). $$
(11)

Let \(\underline{c}\) and \(\overline{c}\) denote the worst and best possible value of the cost criterion, and let \(\underline{e}\) and \(\overline{e}\) denote the worst and best possible value of the effectiveness criterion. This allows us to express V 1(e) and V 2(c) as the following positive affine transformations of the linear partial value functions \(v_{1}(e)=\frac{e - \underline{e}}{\overline{e} - \underline{e}}\) and \(v_{2}(c)=\frac{\underline{c} - c}{\underline{c} - \overline{c}}\):

$$ V_{1}(e) = \frac{\lambda \overline{e} - \lambda \underline{e}}{\lambda \overline{e} - \lambda \underline{e}} (\lambda e - \lambda \underline{e}) + \lambda \underline{e} = (\lambda \overline{e} - \lambda \underline{e}) v_{1}(e) + \lambda \underline{e}, $$
(12)
$$ V_{2}(c) = \frac{\underline{c} - \overline{c}}{\underline{c} - \overline{c}} (\underline{c} - c) - \underline{c} = (\underline{c} - \overline{c}) v_{2}(c) - \underline{c}. $$
(13)

Now, by substituting (12) and (13) in (11), it follows after rewriting that

$$ \hbox{NMB}(c,e,\lambda) = (\lambda \overline{e} - \lambda \underline{e}) v_{1}(e) + (\underline{c} - \overline{c}) v_{2}(c) + \lambda \underline{e} - \underline{c}. $$
(14)

Finally, by normalizing the scaling factors, we obtain the following expression for the NMB function:

$$ \hbox{NMB}(c,e,\lambda) = (\lambda \overline{e} - \lambda \underline{e} + \underline{c} - \overline{c}) (w_{1} v_{1}(e) + w_{2} v_{2}(c)) + \lambda \underline{e} - \underline{c}, $$
(15)

with w 1 and w 2 defined as

$$ w_{1}=\frac{(\lambda \overline{e} - \lambda \underline{e})}{\lambda \overline{e} - \lambda \underline{e} + \underline{c} - \overline{c}}, $$
(16)
$$ w_{2}=\frac{\underline{c} - \overline{c}}{\lambda \overline{e} - \lambda \underline{e} + \underline{c} - \overline{c}}. $$
(17)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Postmus, D., Tervonen, T., van Valkenhoef, G. et al. A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions. Eur J Health Econ 15, 709–716 (2014). https://doi.org/10.1007/s10198-013-0517-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-013-0517-9

Keywords

JEL Classification

Navigation